Cancer epigenomics: DNA methylomes and histone-modification maps

Area of Science:

• Oncology
• Epigenetics
• Genomics

Background:

• Altered epigenetic modifications are fundamental to numerous human diseases, particularly cancer.
• Previous research focused on gene-specific DNA methylation and histone modification patterns in cancer cells.
• CpG-island-promoter hypermethylation was identified as a key mechanism for tumor suppressor gene silencing.

Purpose of the Study:

• To highlight the importance of genome-wide epigenomics in cancer research.
• To advocate for an ambitious research plan to address outstanding questions in cancer epigenetics.
• To leverage recent technological advancements for a comprehensive understanding of cancer epigenetics.

Main Methods:

• Review of existing studies on DNA methylation and histone modification in cancer.
• Emphasis on the shift from gene-by-gene analysis to genome-wide epigenomics.
• Utilizing advanced epigenomics technologies for large-scale analysis.

Main Results:

• Genome-wide approaches are revealing complex epigenetic patterns in cancer.
• These advanced methods offer significant biological insights into cancer development.
• New translational research avenues are emerging from epigenomics studies.

Conclusions:

• Cancer epigenetics research requires an upgrade to a genome-wide epigenomics perspective.
• An ambitious, coordinated plan is needed to tackle complex questions in the field.
• Epigenomics holds the key to deeper understanding and improved therapeutic strategies for cancer.